Navigation Links
Chronos Granules Bone Graft Substitute

ProductsChronos Granules Bone Graft Substitute
Company Synthes, Inc.
Item Chronos Granules Bone Graft Substitute
Features A synthetic cancellous bone graft substitute, which remodels into bone, is easy to use and has a clinical track record of twenty years. Its synthetic origin provides unsurpassed safety. Consists of pure beta-tricalcium phosphate and has an excellent in vivo behavior. Its strength is similar to that of cancellous bone (7.5 1 MPa), and its scaffold provides an ideal structure for osteoconductivity. Gradually resorbed and replaced by new bone, this remodelling process takes 6-18 months. Chronos can be used in all spinal applications instead of cancellous bone graft: postero-lateral fusion, interbody fusion (as cage filling material), vertebrectomies (as filling material for vertebral implants). Chronos has also indications for trauma and cranio-maxillofacial surgery.
Description Synthetic cancellous bone graft substitute (beta-tricalcium phosphate). The use of Chronos is an advantageous alternative to bone harvesting. It shortens operative time, overcomes the limitations in quantity and quality of available bone graft and avoids donor site morbidity.
Info Synthes, Inc.
Customer Service: (800) 523-0322
Web site: http://www.synthes.com

Related medicine products :

1. Conduit TCP Granules Bone Graft
2. TruGraft Synthetic Bone Graft Substitute Granules
3. Grafton Trial Frame
4. Blair-Brown Skin Graft Knife
5. Braithwaite Skin Graft Knife
6. Watson Skin Graft Knife
7. Duragen Dural Graft Matrix
8. I/C Graft Chamber, GDS010
9. I/C Graft Chamber, GDS015
10. I/C Graft Chambers, GDS005
11. Grafton DBM Crunch
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Whole Blood Metals Control contains the major heavy metals of toxicological and environmental importance for whole blood analysis....
Lyphochek Whole Blood Control is a unique product designed to monitor immunosuppressants, red cell folate and lead in whole blood assays. This control has three critical levels for each analyte and i...
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Medicine Products:
(Date:12/21/2013)... Register for the webinar playback: ... together a panel of leading experts to explore current ... The panel makes recommendations on modifying deal approach and ... and cross-border transactions. Register here for the webinar playback. ... a secure virtual data room (VDR) solution that optimises ...
(Date:12/21/2013)... This week, Bioforce USA launched Phase 1 of its new ... is in keeping with the company’s business philosophy : ... make informed choices. Phase II of the site, an ... Company President and CEO, Pierce Sioussat states: “As the flagship ... able to achieve with this new platform. Our online presentation ...
(Date:12/21/2013)... AD Surgical announces the introduction of a new line ... portfolio of surgical products. AD Surgical Universal Sterile ... for simple and effective protection. All the drapes are ... material to prevent strike-through and subsequent contamination of the ... tape and can be used alone or in combination, ...
(Date:12/21/2013)... December 21, 2013 Residents at the San ... enjoying all of the abundance of a rich, traditional holiday season ... On December 10, a large number of residents gathered in the ... Care” event. Displaying a desire to reach out to the community ... they made gift bags for the homeless women of the south ...
(Date:12/21/2013)... (PRWEB) December 21, 2013 Under the ... the department of Computer Science and Software Engineering at ... Shoreline and Yakima to develop a teacher-friendly computer tool ... Johnson, author of Red Flags for Primary Teachers, Dr. ... Helen Spencer of the WA state Council on Aging ...
Breaking Medicine News(10 mins):Health News:Register for Merrill DataSite's Webinar Playback: Best Practices for Strategic Growth: Where to Invest in the Maturing U.S. Economy 2Health News:AD Surgical Introduces a New Line of Universal Sterile Drapes 2Health News:Special Events Keep San Luis Obispo Assisted Living Facility Residents at The Manse On Marsh in the Holiday Spirit 2Health News:How Can University Educators Help Children's Vision? Katie Johnson Works with Graduate Students in Interactive Media and Design to Develop Vision Screening Tool 2
... system for advanced radiation therapy, today announced that Rafael (Ralph) Vaello ... December 1, 2008. Mr. Vaello, who will report to TomoTherapy CEO ... sales and field marketing group for Philips Healthcare’s Oncology Imaging division. ... ...
... conditions that haven,t been studied thoroughly , , MONDAY, Nov. ... it,s the common practice of doctors prescribing a drug ... the one studied by federal regulators that led to ... the scope of the practice, there,s often little evidence ...
... that a drop in blood potassium levels caused by ... the reason why people on those drugs are at ... accelerate loss of fluids, but also deplete important chemicals, ... generally advised to eat bananas and other potassium-rich foods ...
... Cross & Blue Shield of,Rhode Island (BCBSRI) and Care New ... extend CNE participation in the BCBSRI network,until March 31, 2009. ... CNE Hospitals and the CNE VNA as they currently do ... According to BCBSRI President and CEO James E. Purcell and ...
... CINCINNATI, Nov. 24 Dr. Stephen Joffe, Craig Joffe, ... 13D with the U.S.,Securities and Exchange Commission. The ... LCA-Vision, Inc. (Nasdaq: LCAV ), which,operates 77 ... the United States. Dr. Joffe is the founder ...
... 24 Three leading area fertility solutions,agencies today announced the ... manage the risk of egg donors dropping out before the,retrieval ... The "Shared Risk Donor Program" is an initiative by The ... (ARR), both of Chicago. , ...
Cached Medicine News:Health News: TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries 2Health News:Study Calls for Greater Scrutiny of 'Off-Label' Drug Use 2Health News:Study Calls for Greater Scrutiny of 'Off-Label' Drug Use 3Health News:Study Calls for Greater Scrutiny of 'Off-Label' Drug Use 4Health News:Potassium loss from blood pressure drugs may explain higher risk of adult diabetes 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill 3Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill 5Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill 6Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill 7Health News:Three Chicago Area Fertility Agencies Launch 'Shared Risk' Program 2
(Date:12/20/2013)... 20, 2013  Developing and maintaining an efficient ... industry is increasingly challenging due to today,s plethora ... environment where every expense is scrutinized, leaders must ... them to prioritize roles and responsibilities that will ... organization. Recent research by benchmarking firm, ...
(Date:12/20/2013)... -- Today, Analysts, Corner announced new research ... ), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ), ... Healthcare Solutions, Inc. (NASDAQ: MDRX ), and ... these reports free of charge - including full price ... links below. Alexion Pharmaceuticals, Inc. Research Report ...
(Date:12/19/2013)... YORK , Dec. 19, 2013  Intra-Cellular ... the development of therapeutics for CNS disorders, announced ... quotation on the OTC Markets – OTCQB tier ... to begin trading on December 20, 2013. ... (the "Company") is developing novel drugs for the ...
Breaking Medicine Technology:Shifting Marketing Resources in Medical Device Organizations Key to Cutting & Growing Simultaneously 2Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 2Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 3Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 4Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 5Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 6Intra-Cellular Therapies Cleared for Quotation on OTCQB 2Intra-Cellular Therapies Cleared for Quotation on OTCQB 3